247 C. Laurent et al., “Beneficial effects of caffeine in a transgenic model of Alzheimer’s disease-like tau pathology.” Neurobiology of Aging 35, no. 9 (September 2014): 2079–90.
248 F. Yang et al., “Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.” Journal of Biological Chemistry 280, no. 7 (February 2005): 5892–901.
249 K. Ono et al., “Curcumin has potent anti-amyloidogenic effects for Alzheimer’s beta-amyloid fibrils in vitro.” Journal of Neuroscience Research 75, no. 6 (March 2004): 742–50.
250 G. P. Lim et al., “The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.” Journal of Neuroscience: The Official Journal of the Society for Neuroscience 21, no. 21 (November 2001): 8370–77.
251 M. C. Monti et al., “New insights on the interaction mechanism between tau protein and oleocanthal, an extra-virgin olive-oil bioactive component.” Food and Function 2, no. 7 (July 2011): 423–28.
252 A. H. Abuznait et al., “Olive-oil-derived oleocanthal enhances β-amyloid clearance as a potential neuroprotective mechanism against Alzheimer’s disease: in vitro and in vivo studies.” ACS Chemical Neuroscience 4, no. 6 (June 2013): 973–82.
253 A. Frydman-Marom et al., “Orally administrated cinnamon extract reduces β-amyloid oligomerization and corrects cognitive impairment in Alzheimer’s disease animal models.” PloS One 6, no. 1 (January 2011): e16564.
254 T. Lu et al., “Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes.” Nutrition Research 32, no. 6 (June 2012): 408–12.
255 F. Brighenti et al., “Effect of neutralized and native vinegar on blood glucose and acetate responses to a mixed meal in healthy subjects.” European Journal of Clinical Nutrition 49, no. 4 (April 1995): 242–47.
256 E. Ostman et al., “Vinegar supplementation lowers glucose and insulin responses and increases satiety after a bread meal in healthy subjects.” European Journal of Clinical Nutrition 59, no. 9 (September 2005): 983–88.
257 L. Fontana et al., “Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans.” Proceedings of the National Academy of Sciences of the United States of America 101, no. 17 (April 2004): 6659–63.
258 T. E. Meyer et al., “Long-term caloric restriction ameliorates the decline in diastolic function in humans.” Journal of the American College of Cardiology 47, no. 2 (January 2006): 398–402.
259 L. K. Heilbronn et al., “Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial.” JAMA 295, no. 13 (April 2006): 1539–48.
260 K. A. Varady et al., “Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults.” American Journal of Clinical Nutrition 90, no. 5 (November 2009): 1138–43.
261 N. Halberg et al., “Effect of intermittent fasting and refeeding on insulin action in healthy men.” Journal of Applied Physiology 99, no. 6 (December 2005): 2128–36.
262 E. Patterson et al., “Association between dairy food consumption and risk of myocardial infarction in women differs by type of dairy food.” Journal of Nutrition 143, no. 1 (January 2013): 74–79.
263 G. Stix, “Got (skim) milk?: maybe a recipe for obesity and cancer.” Talking Back (blog), Scientific American, July 3, 2013.
264 X. Song et al., “Advanced glycation in D-galactose induced mouse aging model.” Mechanisms of Ageing and Development 108, no. 3 (May 1999): 239–51.
265 X. Cui et al., “Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-α-lipoic acid” Journal of Neuroscience Research 83, no. 8 (June 2006): 1584–90.
266 X. Cui et al., “D-Galactose-caused life shortening in Drosophila melanogaster and Musca domesticais associated with oxidative stress.” Biogerontology 5, no. 5 (October 2004): 317–26.
267 K. Michaëlsson et al., “Milk intake and risk of mortality and fractures in women and men: cohort studies.” BMJ (Clinical Research Ed.) 349 (January 2014): g6015.
268 J. M. Chan et al., “Dairy products, calcium, and prostate cancer risk in the Physicians’ Health Study.” American Journal of Clinical Nutrition 74, no. 4 (October 2001): 549–54.
269 L.-Q. Qin et al., “Milk consumption and circulating insulin-like growth factor-I level: a systematic literature review.” International Journal of Food Sciences and Nutrition 60 Suppl 7 (January 2009): 330–40.
270 M. Park et al., “Consumption of milk and calcium in midlife and the future risk of Parkinson disease.” Neurology 64, no. 6 (March 2005): 1047–51.
271 C. Rodriguez et al., “Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men.” Cancer Epidemiology Biomarkers and Prevention 12, no. 7 (July 2003): 597–603.
272 H. A. Bischoff-Ferrari et al., “Milk intake and risk of hip fracture in men and women: a meta-analysis of prospective cohort studies.” Journal of Bone and Mineral Research 26, no. 4 (April 2011): 833–39.
273 J. J. B. Anderson et al., “Calcium intake from diet and supplements and the risk of coronary artery calcification and its progression among older adults: 10-year follow-up of the multi-ethnic study of atherosclerosis (MESA).” Journal of the American Heart Association 5, no. 10 (October 2016): e003815.
274 K. Verburgh, “Nutrigerontology: why we need a new scientific discipline to develop diets and guidelines to reduce the risk of aging-related diseases.” Aging Cell (December 2014).
275 B. Vellas et al., “Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders.” Current Alzheimer Research 6, no. 2 (April 2009): 144–51.
276 M. Asif et al., “An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.” Proceedings of the National Academy of Sciences of the United States of America 97, no. 6 (March 2000): 2809–13.
277 P. V Vaitkevicius et al., “A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys.” Proceedings of the National Academy of Sciences of the United States of America 98, no. 3 (January 2001): 1171–75.
278 D. A. Kass et al., “Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.” Circulation 104, no. 13 (September 2001): 1464–70.
